Drug approval status and recommendations for listing on public formularies: a Canadian cohort analysis

OBJECTIVES: Investigate if the recommendations by the Common Drug Review (CDR) and the pan-Canadian Oncology Drug Review (pCODR) to provincial, territorial and federal drug plans about whether to list non-oncology and oncology drug-indication combinations on their formularies are associated with whe...

Descripción completa

Detalles Bibliográficos
Autor principal: Lexchin, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Health Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665246/
https://www.ncbi.nlm.nih.gov/pubmed/29061631
http://dx.doi.org/10.1136/bmjopen-2017-018372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665246/
https://www.ncbi.nlm.nih.gov/pubmed/29061631
http://dx.doi.org/10.1136/bmjopen-2017-018372

Ejemplares similares